Hansson O - Search Results

1

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.

Chouraki V, Beiser A, Younkin L, Preis SR, Weinstein G, Hansson O, Skoog I, Lambert JC, Au R, Launer L, Wolf PA, Younkin S, Seshadri S. Chouraki V, et al. Among authors: hansson o. Alzheimers Dement. 2015 Mar;11(3):249-57.e1. doi: 10.1016/j.jalz.2014.07.001. Epub 2014 Sep 10. Alzheimers Dement. 2015. PMID: 25217292 Free PMC article.

2

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Hansson O, et al. Lancet Neurol. 2006 Mar;5(3):228-34. doi: 10.1016/S1474-4422(06)70355-6. Lancet Neurol. 2006. PMID: 16488378

3

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K. Hansson O, et al. Dement Geriatr Cogn Disord. 2007;23(5):316-20. doi: 10.1159/000100926. Epub 2007 Mar 19. Dement Geriatr Cogn Disord. 2007. PMID: 17374949

4

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.

Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S. Hansson O, et al. Neurobiol Aging. 2009 Feb;30(2):165-73. doi: 10.1016/j.neurobiolaging.2007.06.009. Epub 2007 Jul 23. Neurobiol Aging. 2009. PMID: 17646035

5

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

Höglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J. Höglund K, et al. Among authors: hansson o. Neurodegener Dis. 2008;5(5):268-76. doi: 10.1159/000119457. Epub 2008 Feb 29. Neurodegener Dis. 2008. PMID: 18309230

6

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, Wallin A, Minthon L, Blennow K. Hansson O, et al. Neurobiol Aging. 2010 Mar;31(3):357-67. doi: 10.1016/j.neurobiolaging.2008.03.027. Epub 2008 May 19. Neurobiol Aging. 2010. PMID: 18486992

7

Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease.

Buchhave P, Stomrud E, Warkentin S, Blennow K, Minthon L, Hansson O. Buchhave P, et al. Among authors: hansson o. Dement Geriatr Cogn Disord. 2008;25(6):544-52. doi: 10.1159/000137379. Epub 2008 Jun 6. Dement Geriatr Cogn Disord. 2008. PMID: 18535375

8

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.

Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, Simon AJ, Blennow K. Zetterberg H, et al. Among authors: hansson o. Arch Neurol. 2008 Aug;65(8):1102-7. doi: 10.1001/archneur.65.8.1102. Arch Neurol. 2008. PMID: 18695061

9

Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls.

Andersson M, Hansson O, Minthon L, Rosén I, Londos E. Andersson M, et al. Among authors: hansson o. Dement Geriatr Cogn Disord. 2008;26(3):284-90. doi: 10.1159/000160962. Epub 2008 Oct 8. Dement Geriatr Cogn Disord. 2008. PMID: 18841014

10

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

Buchhave P, Janciauskiene S, Zetterberg H, Blennow K, Minthon L, Hansson O. Buchhave P, et al. Among authors: hansson o. Neurosci Lett. 2009 Jan 23;450(1):56-9. doi: 10.1016/j.neulet.2008.10.091. Epub 2008 Nov 5. Neurosci Lett. 2009. PMID: 18996438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

759 results

Search Page